Hillel, Inbar
Gazit, Eran
Nieuwboer, Alice
Avanzino, Laura
Rochester, Lynn
Cereatti, Andrea
Croce, Ugo Della
Rikkert, Marcel Olde
Bloem, Bastiaan R.
Pelosin, Elisa
Del Din, Silvia
Ginis, Pieter
Giladi, Nir
Mirelman, Anat
Hausdorff, Jeffrey M.
Funding for this research was provided by:
FP7 Ideas: European Research Council (FP7 - 278169)
Article History
Received: 5 February 2019
Accepted: 11 April 2019
First Online: 3 May 2019
Ethics approval and consent to participate
: The study was approved by local Helsinki committees. Written informed consent was obtained from all individual participants included in this study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: All authors declare that they have no competing financial interests. Nir Giladi, Anat Mirelman and Jeff Hausdorff report having submitted a patent application on the use of body-fixed sensors for assessing symptoms in patients with Parkinson’s disease, the intellectual property rights for which are held by the Tel Aviv Medical Center.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.